Co‐IP assays revealed enhanced interaction between LATS1 and YAP in TWF2‐knockdown RCC cells (Figure 5I), while this interaction was attenuated in TWF2‐overexpressing cells (Figure 5J), suggesting that TWF2 competes with LATS1 for YAP binding. The gene discussed is LATS1; the disease is renal cell carcinoma.